THE CORETEC GROUP INC (CRTG) Financials

CRTG

FY2023 annual

Revenue $0 n/m YoY

Net Income -$2.3M n/m YoY

Free Cash Flow -$1.9M n/m YoY

Operating Cash Flow -$1.8M n/m YoY

Market Cap $1.1M as of Oct 21, 2026

Price / Sales n/m revenue is not positive, FY2023

Price / Earnings n/m net loss, so no earnings multiple, FY2023

Price / Book n/m negative shareholder equity, so no book multiple, Q2 FY2024

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 21, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2024, ended Jun 30, 2024 Reported Aug 14, 2024 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2024, filed Aug 14, 2024. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CRTG SEC filings page.

THE CORETEC GROUP INC (CRTG) reported $0 in revenue for fiscal year 2023. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CRTG FY2023 2026-10-22

The company remains development-stage: operating cash flow was negative while liabilities reached 93.7% of assets, leaving little equity cushion.

From FY2022 to FY2023, assets shrank 51.4% while liabilities fell only 7.9%. Equity then fell 94.0%, meaning the balance-sheet contraction was absorbed mainly by owners’ capital, not by a proportionate reduction in obligations.

FY2023 net loss was $2.31M while operating cash flow was -$1.82M, so accounting losses were accompanied by substantial cash use. Free cash flow was -$1.87M after $52.9K of capital expenditures, showing that reinvestment was not the main driver of the cash shortfall.

R&D was $513K in FY2023 versus SG&A of $1.79M, indicating a development-stage cost structure with overhead larger than direct research spending. Debt-to-equity reached 9.1x while the reported liquidity comparison was 3.5 months of latest annual operating outflow, making financing central to the reported structure.

Financial Health Signals

Financial health score not available

THE CORETEC GROUP INC does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial

1/8

THE CORETEC GROUP INC passes 1 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), the one computable operating efficiency signal (asset turnover improving) does not pass.

Earnings Quality No Cash Backing

N/A

THE CORETEC GROUP INC reported a net loss of $2.3M while operations used $1.8M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

YoYn/m

QoQn/m

THE CORETEC GROUP INC generated $0 in revenue in Q2 2024. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Net Income

-$334K

YoYn/m

QoQn/m

THE CORETEC GROUP INC reported a net loss of $334K in Q2 2024. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

EBITDA

Not reported for Q2 2024.

EPS (Diluted)

Not reported for Q2 2024.

Cash & Balance Sheet

Cash & Debt

$4K

YoY-99.7%

QoQ-96.1%

5Y CAGR-33.4%

THE CORETEC GROUP INC held $4K in cash against $390K in long-term debt as of Q2 2024.

Shares Outstanding

337M

YoY+18.5%

QoQ+6.9%

THE CORETEC GROUP INC had 337M shares outstanding in Q2 2024. This represents an increase of 18.5% from the same quarter a year earlier. Against the prior quarter it is up 6.9%.

Free Cash Flow

Not reported for Q2 2024.

Dividends Per Share

Not reported for Q2 2024.

Margins & Returns

None of these metrics is reported for Q2 2024.

Capital Allocation

R&D Spending

$60K

YoY-50.8%

QoQ-51.2%

THE CORETEC GROUP INC invested $60K in research and development in Q2 2024. This represents a decrease of 50.8% from the same quarter a year earlier. Against the prior quarter it is down 51.2%.

Share Buybacks

Not reported for Q2 2024.

Capital Expenditures

Not reported for Q2 2024.

CRTG Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CRTG quarterly income statement

Metric	TTM	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K	FY1010-K	FY0910-K
Revenue	N/A	$0n/m	$0n/m	$0n/m	$0	N/A	N/A	N/A	$0-100.0%	$5K-94.0%	$86K+77.2%	$48K-24.0%	$64K-28.7%	$89K-15.8%	$106K	N/A
R&D Expenses	N/A	$513K-4.3%	$536K+14.0%	$470K+209.5%	$152K+2.0%	$149K+75.0%	$85K-81.4%	$456K+51.6%	$301K+530.5%	$48K-76.0%	$199K-46.8%	$373K	N/A	N/A	$469K	N/A
SG&A Expenses	N/A	$1.8M-16.0%	$2.1M-62.0%	$5.6M+445.6%	$1.0M-27.4%	$1.4M+88.8%	$751K-19.8%	$937K+144.1%	$384K	N/A	N/A	N/A	N/A	N/A	$1.1M	N/A
Interest Expense	N/A	$218K+7.3%	$203K-11.7%	$230K-65.5%	$665K+131.5%	$287K-27.3%	$395K+23.4%	$320K+432.8%	$60K+4.0%	$58K-23.7%	$76K-5.7%	$80K-50.8%	$163K+339.1%	$37K-51.0%	$76K	N/A
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	N/A	-$2.3Mn/m	-$2.9Mn/m	-$6.3Mn/m	-$1.8Mn/m	-$1.9Mn/m	-$1.0Mn/m	-$1.7Mn/m	-$745K	N/A	N/A	N/A	N/A	N/A	-$1.5Mn/m	-$1.6M
EPS (Basic)	N/A	-$0.01n/m	-$0.01n/m	-$0.03n/m	-$0.01	-$0.03	-$0.01	-$0.07	-$0.60n/m	$0.00n/m	$0.00	-$0.01	-$0.05	-$0.07n/m	$0.00	N/A
EPS (Diluted)	—	N/A	N/A	-$0.03n/m	-$0.01	-$0.03	-$0.01	-$0.07	-$0.60n/m	$0.00n/m	$0.00	-$0.01	-$0.05	-$0.07n/m	$0.00	N/A

Metric	Q2'2410-Q	Q1'2410-Q	Q4'2310-Q	Q3'2310-Q	Q2'2310-Q	Q1'2310-Q	Q4'2210-K	Q3'2210-Q
Revenue	$0n/m	$0n/m	N/A	$0n/m	$0n/m	$0n/m	N/A	$0n/m
R&D Expenses	$60K-50.8%	$122K+9.4%	N/A	$101K+26.1%	$121K-0.3%	$112K-43.6%	N/A	$80K-58.3%
SG&A Expenses	$235K-23.2%	$358K+3.1%	N/A	$306K+1.5%	$306K-30.2%	$347K-19.9%	N/A	$301K-87.9%
Interest Expense	$40K-24.7%	$45K-17.7%	N/A	$54K+3.1%	$53K+11.4%	$54K+12.7%	N/A	$53K+19.9%
Net Income	-$334Kn/m	-$524Kn/m	N/A	-$457Kn/m	-$474Kn/m	-$507Kn/m	N/A	-$432Kn/m
EPS (Basic)	$0.00n/m	$0.00n/m	$0.00n/m	$0.00n/m	$0.00n/m	$0.00n/m	$0.00n/m	$0.00n/m

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, Operating Income, EBITDA, Income Tax, EPS (Diluted), Diluted Shares (Avg).

CRTG Balance Sheet

CRTG quarterly balance sheet

Metric	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K	FY1010-K	FY0910-K
Total Assets	$1.8M-51.4%	$3.6M-32.4%	$5.4M+270.6%	$1.4M-0.7%	$1.5M+1.8%	$1.4M-27.6%	$2.0M+22.5%	$1.6M+6947.2%	$23K-59.9%	$57K-49.2%	$112K+13.6%	$99K+20.4%	$82K-80.1%	$414K	N/A
Current Assets	$657K-73.4%	$2.5M-41.0%	$4.2M+1970.8%	$202K+37.6%	$147K+256.4%	$41K-91.9%	$506K+769.0%	$58K+272.4%	$16K-69.7%	$52K-39.0%	$85K-8.3%	$92K+31.8%	$70K-82.3%	$396K	N/A
Cash & Equivalents	$524K-77.8%	$2.4M-41.9%	$4.1M+18142.6%	$22K-61.8%	$58K+1353.4%	$4K-99.1%	$471K+79130.6%	$594-93.3%	$9K-74.4%	$34K-51.3%	$71K+5142.1%	$1K-92.4%	$18K-95.2%	$367K+32735.5%	$1K
Short-Term Investments	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$0n/m	$0-100.0%	$78K+361.3%	$17K+139.7%	$7K	N/A
Long-Term Investments	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0
Goodwill	$166K0.0%	$166K0.0%	$166K0.0%	$166K0.0%	$166K0.0%	$166K0.0%	$166K0.0%	$166Kn/m	$0	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$1.7M-7.9%	$1.8M+20.0%	$1.5M+110.7%	$709K-8.5%	$775K-73.2%	$2.9M+14.0%	$2.5M+57.6%	$1.6M+917.3%	$158K-84.3%	$1.0M-30.5%	$1.4M-7.6%	$1.6M+18.0%	$1.3M-34.9%	$2.0M	N/A
Current Liabilities	$647K+71.1%	$378K+23.2%	$307K-30.6%	$443K-32.4%	$655K-77.3%	$2.9M+19.9%	$2.4M+334.9%	$554K+1911.1%	$28K-97.3%	$1.0M+4.5%	$963K-4.5%	$1.0M+38.2%	$730K-36.5%	$1.1M	N/A
Non-Current Liabilities	$1.0M-29.1%	$1.4M+19.1%	$1.2M+345.4%	$267K+121.2%	$121Kn/m	$0-100.0%	$124K-88.2%	$1.1M+707.5%	$131Kn/m	$0-100.0%	$486K-13.2%	$559K-6.6%	$599K-32.7%	$891K	N/A
Long-Term Debt	$1.0M-29.1%	$1.4M	N/A	$267K	N/A	N/A	N/A	N/A	$0-100.0%	$406Kn/m	$0-100.0%	$74K-35.1%	$113K-72.0%	$405K	N/A
Total Equity	$110K-94.0%	$1.8M-52.7%	$3.9M+424.3%	$737K+8.3%	$680Kn/m	-$1.5Mn/m	-$559K-14208.7%	$4Kn/m	-$135Kn/m	-$950Kn/m	-$1.3Mn/m	-$1.5Mn/m	-$1.2Mn/m	-$1.6Mn/m	-$1.8M
Retained Earnings	-$18.7Mn/m	-$16.3Mn/m	-$13.5Mn/m	-$7.3Mn/m	-$5.5Mn/m	-$3.6Mn/m	-$2.6Mn/m	-$880Kn/m	-$135Kn/m	-$21.3M	N/A	N/A	N/A	N/A	N/A

Metric	Q2'2410-Q	Q1'2410-Q	Q4'2310-Q	Q3'2310-Q	Q2'2310-Q	Q1'2310-Q	Q4'2210-K	Q3'2210-Q
Total Assets	$1.3M-48.8%	$1.3M-59.0%	$1.8M-51.4%	$2.3M-42.8%	$2.6M-39.8%	$3.1M-35.9%	$3.6M-32.4%	$4.1M-28.0%
Current Assets	$290K-80.4%	$203K-89.8%	$657K-73.4%	$1.2M-58.5%	$1.5M-53.3%	$2.0M-45.5%	$2.5M-41.0%	$2.9M-35.2%
Cash & Equivalents	$4K-99.7%	$115K-94.1%	$524K-77.8%	$1.0M-63.2%	$1.4M-53.3%	$1.9M-45.4%	$2.4M-41.9%	$2.8M-36.3%
Short-Term Investments	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m
Long-Term Investments	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m
Goodwill	$166K0.0%	$166K0.0%	$166K0.0%	$166K0.0%	$166K0.0%	$166K0.0%	$166K0.0%	$166K0.0%
Total Liabilities	$2.0M+12.8%	$1.7M-6.6%	$1.7M-7.9%	$1.9M+6.9%	$1.8M+6.1%	$1.8M+12.7%	$1.8M+20.0%	$1.8M+18.6%
Current Liabilities	$1.6M+408.4%	$679K+53.0%	$647K+71.1%	$672K+70.2%	$314K-29.1%	$444K+10.6%	$378K+23.2%	$395K-45.1%
Non-Current Liabilities	$390K-73.1%	$1.0M-26.0%	$1.0M-29.1%	$1.2M-11.0%	$1.4M+18.9%	$1.4M+13.4%	$1.4M+19.1%	$1.4M+76.3%
Long-Term Debt	$390K-73.1%	$1.0M-26.0%	$1.0M-29.1%	$1.2M	$1.4M	$1.4M	$1.4M	N/A
Total Equity	-$643K-174.2%	-$405K-130.7%	$110K-94.0%	$415K-81.8%	$866K-68.0%	$1.3M-59.6%	$1.8M-52.7%	$2.3M-45.0%
Retained Earnings	-$19.5Mn/m	-$19.2Mn/m	-$18.7Mn/m	-$17.8Mn/m	-$17.3Mn/m	-$16.9Mn/m	-$16.3Mn/m	-$15.2Mn/m

Not reported in any period shown, so not listed: Inventory, Accounts Receivable.

CRTG Cash Flow Statement

CRTG quarterly cash flow statement

Metric	TTM	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K	FY1010-K	FY0910-K
Operating Cash Flow	-$1.7M	-$1.8Mn/m	-$1.8Mn/m	-$1.1Mn/m	-$1.4Mn/m	-$612Kn/m	-$635Kn/m	-$835Kn/m	-$573K	N/A	N/A	N/A	N/A	N/A	-$511K	N/A
Depreciation & Amortization	N/A	$95K+6.4%	$89K+9.8%	$81K+1.3%	$80K-0.8%	$81K0.0%	$81K-13.9%	$94K+231.1%	$28K	N/A	$0-100.0%	$4K-22.6%	$6K-11.3%	$6K+1.1%	$6K	N/A
Stock-Based Compensation	N/A	$564K-26.0%	$762K-83.4%	$4.6M+4872.5%	$92K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Capital Expenditures	N/A	$53K-34.1%	$80Kn/m	$0	N/A	N/A	N/A	$2Kn/m	$0	N/A	N/A	$0n/m	$0-100.0%	$998-69.3%	$3K	N/A
Free Cash Flow	N/A	-$1.9Mn/m	-$1.9Mn/m	-$1.1M	N/A	N/A	N/A	-$837Kn/m	-$573K	N/A	N/A	N/A	N/A	N/A	-$514K	N/A
Investing Cash Flow	N/A	-$49Kn/m	-$80Kn/m	-$12K	N/A	N/A	N/A	$232-99.6%	$61K	N/A	N/A	$0n/m	$0n/m	-$998n/m	-$3K	N/A
Financing Cash Flow	$250K	$35K-84.8%	$232K-95.5%	$5.2M+291.6%	$1.3M+97.6%	$667K+295.5%	$169K-87.1%	$1.3M+158.9%	$504K	N/A	N/A	N/A	N/A	N/A	$880K	N/A

Metric	Q2'2410-Q	Q1'2410-Q	Q4'2310-Q	Q3'2310-Q	Q2'2310-Q	Q1'2310-Q	Q4'2210-K	Q3'2210-Q
Operating Cash Flow	-$312Kn/m	-$362Kn/m	-$604Kn/m	-$410Kn/m	-$422Kn/m	-$382Kn/m	-$492Kn/m	-$481Kn/m
Depreciation & Amortization	$25K+6.9%	$25K+6.9%	$24K+6.2%	$25K+7.7%	$23K+1.1%	$23K+11.0%	$23K+11.5%	$23K+10.7%
Stock-Based Compensation	N/A	$0n/m	N/A	N/A	N/A	$0-100.0%	N/A	N/A
Capital Expenditures	N/A	N/A	$7Kn/m	$5K-33.3%	$41K-38.6%	$0-100.0%	$0n/m	$7Kn/m
Free Cash Flow	N/A	N/A	-$611Kn/m	-$415Kn/m	-$464Kn/m	-$382Kn/m	-$492Kn/m	-$488Kn/m
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	$0n/m	-$7Kn/m
Financing Cash Flow	$202Kn/m	-$47Kn/m	$111K+52.8%	-$15K-109.5%	-$30Kn/m	-$30Kn/m	$72Kn/m	$160Kn/m

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

CRTG Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CRTG quarterly financial ratios

Metric	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K	FY1010-K	FY0910-K
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-1436.7%	N/A
Return on Equity	-2095.1%-1938.5pp	-156.6%+5.6pp	-162.2%+88.1pp	-250.3%+22.2pp	-272.5%	N/A	N/A	-18790.4%	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	-131.0%-52.0pp	-79.1%+37.9pp	-117.0%+10.6pp	-127.6%-0.2pp	-127.4%-54.2pp	-73.2%+13.5pp	-86.7%-40.5pp	-46.2%	N/A	N/A	N/A	N/A	N/A	-368.1%	N/A
Current Ratio	1.01-5.5x	6.53-7.1x	13.63+13.2x	0.46+0.2x	0.22+0.2x	0.01-0.2x	0.21+0.1x	0.10-0.5x	0.57+0.5x	0.050.0x	0.090.0x	0.090.0x	0.10-0.2x	0.34	N/A
Debt-to-Equity	9.11+8.3x	0.77	N/A	0.36	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Liabilities-to-Equity	14.99+14.0x	0.98+0.6x	0.39-0.6x	0.96-0.2x	1.14	N/A	N/A	405.82	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Asset Turnover	0.000.0x	0.000.0x	0.000.0x	0.00	N/A	N/A	N/A	0.00-0.2x	0.22-1.3x	1.50+1.1x	0.43-0.2x	0.64-0.4x	1.09+0.8x	0.26	N/A
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-485.0%	N/A

Metric	Q2'2410-Q	Q1'2410-Q	Q4'2310-Q	Q3'2310-Q	Q2'2310-Q	Q1'2310-Q	Q4'2210-K	Q3'2210-Q
Return on Equity	N/A	N/A	N/A	-109.9%-91.0pp	-54.8%-32.3pp	-38.4%-17.6pp	N/A	-18.9%+45.4pp
Return on Assets	-24.9%-6.8pp	-40.8%-24.6pp	N/A	-19.6%-9.0pp	-18.1%-4.1pp	-16.2%-2.3pp	N/A	-10.6%+36.6pp
Current Ratio	0.18-4.5x	0.30-4.2x	1.01-5.5x	1.80-5.6x	4.71-2.5x	4.51-4.6x	6.53-7.1x	7.36+1.1x
Debt-to-Equity	N/A	N/A	9.11+8.3x	3.00	1.67	1.03	0.77	N/A
Liabilities-to-Equity	N/A	N/A	14.99+14.0x	4.61+3.8x	2.03+1.4x	1.37+0.9x	0.98+0.6x	0.78+0.4x
Asset Turnover	0.000.0x	0.000.0x	N/A	0.000.0x	0.000.0x	0.000.0x	N/A	0.000.0x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
THE CORETEC GROUP INC CRTG	FY2023	$0	-$2.3M	N/A	$1.1M	—
IIOT-OXYS INC ITOX	FY2025	$0	N/A	N/A	$410K	—

Where THE CORETEC GROUP INC Ranks

Frequently Asked Questions

What is THE CORETEC GROUP INC's annual revenue?

THE CORETEC GROUP INC (CRTG) reported $0 in total revenue for fiscal year 2023. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Is THE CORETEC GROUP INC profitable?

No, THE CORETEC GROUP INC (CRTG) reported a net loss of $2.3M in fiscal year 2023.

How much debt does THE CORETEC GROUP INC have?

As of fiscal year 2023, THE CORETEC GROUP INC (CRTG) had $524K in cash and equivalents against $1.0M in long-term debt.

What is THE CORETEC GROUP INC's return on equity (ROE)?

THE CORETEC GROUP INC (CRTG) has a return on equity of -2095.1% for fiscal year 2023, measuring how efficiently the company generates profit from shareholder equity.

What is THE CORETEC GROUP INC's free cash flow?

THE CORETEC GROUP INC (CRTG) recorded an outflow of $1.9M in free cash flow during fiscal year 2023. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is THE CORETEC GROUP INC's operating cash flow?

THE CORETEC GROUP INC (CRTG) recorded an outflow of $1.8M in operating cash flow during fiscal year 2023, representing cash used by core business activities.

What are THE CORETEC GROUP INC's total assets?

THE CORETEC GROUP INC (CRTG) had $1.8M in total assets as of fiscal year 2023, including both current and long-term assets.

What are THE CORETEC GROUP INC's capital expenditures?

THE CORETEC GROUP INC (CRTG) invested $53K in capital expenditures during fiscal year 2023, funding long-term assets and infrastructure.

How much does THE CORETEC GROUP INC spend on research and development?

THE CORETEC GROUP INC (CRTG) invested $513K in research and development during fiscal year 2023.

How many shares does THE CORETEC GROUP INC have outstanding?

THE CORETEC GROUP INC (CRTG) had 301M shares outstanding as of fiscal year 2023.

What is THE CORETEC GROUP INC's current ratio?

THE CORETEC GROUP INC (CRTG) had a current ratio of 1.01 as of fiscal year 2023, which is considered adequate.

What is THE CORETEC GROUP INC's debt-to-equity ratio?

THE CORETEC GROUP INC (CRTG) had a debt-to-equity ratio of 9.11 as of fiscal year 2023. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.

What is THE CORETEC GROUP INC's liabilities-to-equity ratio?

THE CORETEC GROUP INC (CRTG) had a liabilities-to-equity ratio of 14.99 as of fiscal year 2023, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.

What is THE CORETEC GROUP INC's return on assets (ROA)?

THE CORETEC GROUP INC (CRTG) had a return on assets of -131.0% for fiscal year 2023, measuring how efficiently the company uses its assets to generate profit.

What is THE CORETEC GROUP INC's P/E ratio?

THE CORETEC GROUP INC (CRTG) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2023). The market capitalization is $1.1M as of Oct 21, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is THE CORETEC GROUP INC's price-to-sales ratio?

THE CORETEC GROUP INC (CRTG) has no price-to-sales ratio at the moment: revenue is not positive (FY2023). The market capitalization is $1.1M as of Oct 21, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

How does THE CORETEC GROUP INC's liquidity compare with its operating cash outflow?

At the end of fiscal year 2023, THE CORETEC GROUP INC (CRTG) held $524K in cash, cash equivalents and investments, and reported an operating cash outflow of $1.8M over that year. Dividing the one by the other, the reported balance equals about 3 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

What is THE CORETEC GROUP INC's Piotroski F-Score?

THE CORETEC GROUP INC (CRTG) has a Piotroski F-Score of 1 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are THE CORETEC GROUP INC's earnings high quality?

THE CORETEC GROUP INC (CRTG) reported a net loss of $2.3M while operations used $1.8M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.